Minerva Neurosciences Inc... (NERV)
NASDAQ: NERV
· Real-Time Price · USD
2.26
0.46 (25.91%)
At close: Aug 15, 2025, 3:59 PM
2.32
2.85%
After-hours: Aug 15, 2025, 07:47 PM EDT
Minerva Neurosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.27M | 5,710.9B | -8.23M | -8.57M | -9.02M | -6.9M | -6.19M | -6.97M | -6.73M | -6.9M | -8.72M | -9.76M | -21.31M | -9.21M | -10.59M | -8.8M |
Depreciation & Amortization | 1.36K | 5.62K | 7.75K | 7.75K | 7.75K | 7.75K | 7.75K | 7.75K | 6.38K | 2.13K | n/a | n/a | 101.68M | 14.94K | 44.01K | 42.83K |
Stock-Based Compensation | 249.65K | 307.71K | 329.32K | 438.85K | 611.06K | 371.94K | 608.91K | 376.46K | 947.68K | 1.04M | 1.07M | 1.05M | 1.2M | 1.11M | 1.38M | 1.52M |
Other Working Capital | -2.2M | -1.15M | 2.25M | 147.45K | -188.14K | -547.03K | 335.78K | 4.5M | -700.65K | -4.56M | 693.34K | 1.39M | -512.42K | -1.84M | 1.16M | 598.01K |
Other Non-Cash Items | n/a | -20,094.7B | 3.26M | 3.07M | -5.64M | 6.9M | 2.03M | 1.98M | 1.93M | 1.88M | 1.83M | 1.78M | -84.75M | 1.69M | 1.61M | 1.3M |
Deferred Income Tax | n/a | n/a | n/a | n/a | 7.83M | -7.83M | n/a | n/a | n/a | n/a | n/a | n/a | -1.8M | n/a | n/a | n/a |
Change in Working Capital | -1.15M | -1.42M | 1.65M | -222.3K | 222.11K | 549.79K | -326.96K | 4.49M | -263.87K | -5.55M | 626.9K | 1.12M | 140.29K | -2.24M | 1.62M | 732.02K |
Operating Cash Flow | -5.17M | -14,383.8B | -3.94M | -6.09M | -5.99M | -6.9M | -3.87M | -115.41K | -4.11M | -9.53M | -5.19M | -5.81M | -4.83M | -8.63M | -5.92M | -5.22M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.33K | -2.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.33K | 2.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | -415.9M | -86.69K | 19.69M | n/a | n/a | -5 | -5 | n/a | 59.94B | n/a | n/a | 60M |
Financial Cash Flow | n/a | n/a | n/a | n/a | 19.58B | -86.69K | 19.69M | n/a | n/a | -5 | -5 | n/a | 59.94B | n/a | n/a | 60M |
Net Cash Flow | -5.17M | -4.35M | -3.94M | -6.09M | -5.99M | -58.8M | 15.82M | -115.41K | -4.13M | -9.53M | -5.19M | -5.81M | -4.83M | -8.63M | -5.92M | 54.78M |
Free Cash Flow | -5.17M | -14,383.8B | -3.94M | -6.09M | -5.99M | -6.9M | -3.87M | -115.41K | -4.13M | -9.53M | -5.19M | -5.81M | -4.83M | -8.63M | -5.92M | -5.22M |